ROBERT C HOOD
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism
- Where
- BEAUMONT, TX
- NPI
- 1053321539
- Received
- $1,299,050 in 2,487 records, 2019 to 2025 ($1,296,780 general, $2,270 research)
- As principal investigator
- $181,807 of research payments to others in 97 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 246 | $140,108 |
| 2024 | General payment | 316 | $132,742 |
| 2023 | General payment | 297 | $128,874 |
| 2023 | Research payment | 2 | $1,070 |
| 2022 | General payment | 351 | $217,422 |
| 2021 | General payment | 267 | $139,775 |
| 2020 | General payment | 350 | $173,093 |
| 2020 | Research payment | 1 | $1,200 |
| 2019 | General payment | 657 | $364,763 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 629 | $955,575 |
| Travel and Lodging | 615 | $268,983 |
| Food and Beverage | 1,218 | $38,053 |
| Consulting Fee | 19 | $34,111 |
| Research payment | 3 | $2,270 |
| Education | 3 | $56 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-02 | Amgen Inc. | $1,429 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-11-21 | Amgen Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-11-21 | Amgen Inc. | $367 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-11-19 | Amgen Inc. | $121 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-11-13 | Amgen Inc. | $105 | Travel and Lodging | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-11-13 | Amgen Inc. | $21 | Food and Beverage | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-11-11 | Amgen Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-11-11 | Amgen Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-11-11 | Amgen Inc. | $2,199 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-11-11 | Amgen Inc. | $734 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-11-07 | Amgen Inc. | $305 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-11-06 | Amgen Inc. | $134 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-11-05 | Amgen Inc. | $116 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-11-04 | Novo Nordisk Inc | $4,068 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-11-04 | Novo Nordisk Inc | $229 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-11-04 | Novo Nordisk Inc | $100 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-11-04 | Novo Nordisk Inc | $15 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-30 | Novo Nordisk Inc | $3,836 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-30 | Novo Nordisk Inc | $1,274 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-30 | Novo Nordisk Inc | $119 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-16 | Amgen Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-10-16 | Amgen Inc. | $367 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-10-15 | Amgen Inc. | $1,270 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-10-14 | Amgen Inc. | $12 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-10-10 | Amgen Inc. | $434 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-10-07 | Novo Nordisk Inc | $494 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-03 | Dexcom, Inc. | $13 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-10-02 | Novo Nordisk Inc | $5,696 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-02 | Novo Nordisk Inc | $1,473 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-02 | Novo Nordisk Inc | $364 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-02 | Novo Nordisk Inc | $142 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-02 | Novo Nordisk Inc | $140 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-01 | Dexcom, Inc. | $18 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-09-30 | Novo Nordisk Inc | $3,836 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-09-30 | Novo Nordisk Inc | $1,068 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-09-30 | Novo Nordisk Inc | $121 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-09-30 | Medtronic, Inc. | $15 | Food and Beverage | In-kind items and services | MINIMED 780G Device, Durable Pump | 2025 | |
| 2025-09-29 | Amgen Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-09-29 | Amgen Inc. | $1,394 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-09-29 | Amgen Inc. | $734 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-09-29 | Madrigal Pharmaceuticals | $26 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-09-29 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2025 | |
| 2025-09-26 | Amgen Inc. | $152 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-09-25 | Amgen Inc. | $134 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-09-24 | Sequel Med Tech, LLC | $29 | Food and Beverage | In-kind items and services | TWIIST Device, AUTOMATED INSULIN DELIVERY DEVICE | 2025 | |
| 2025-09-24 | Insulet Corporation | $20 | Food and Beverage | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2025 | |
| 2025-09-23 | Novo Nordisk Inc | $6 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-09-17 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-16 | Medtronic, Inc. | $21 | Food and Beverage | In-kind items and services | MINIMED 780G Device, Durable Pump | 2025 | |
| 2025-09-09 | Esperion Therapeutics, Inc. | $14 | Food and Beverage | In-kind items and services | NEXLETOL Drug, ANTILIPEMIC AGENTS | 2025 | |
| 2025-09-08 | SANOFI-AVENTIS U.S. LLC | $23 | Food and Beverage | In-kind items and services | TZIELD Biological, Endocrine & Metabolic Diseases | 2025 | |
| 2025-09-03 | KYOWA KIRIN, INC. | $25 | Food and Beverage | In-kind items and services | CRYSVITA Drug, FIBROBLAST GROWTH FACTOR 23 FGF23 BLOCKING ANTIBODY | 2025 | |
| 2025-09-02 | Corcept Therapeutics | $18 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2025 | |
| 2025-08-26 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-08-26 | Lilly USA, LLC | $15 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-08-25 | Amgen Inc. | $17 | Food and Beverage | In-kind items and services | TEPEZZA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-08-20 | Lilly USA, LLC | $23 | Travel and Lodging | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-08-20 | Dexcom, Inc. | $14 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-08-14 | Medtronic, Inc. | $1,822 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-08-14 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-08-14 | Lilly USA, LLC | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-08-14 | Amgen Inc. | $165 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-08-14 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | SYNTHROID Drug, IMMUNOLOGY | 2025 | |
| 2025-08-13 | Novartis Pharmaceuticals Corporation | $17 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2025 | |
| 2025-08-12 | Lilly USA, LLC | $22 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-08-04 | SANOFI-AVENTIS U.S. LLC | $24 | Food and Beverage | In-kind items and services | TZIELD Biological, Endocrine & Metabolic Diseases | 2025 | |
| 2025-07-30 | Medtronic, Inc. | $234 | Travel and Lodging | In-kind items and services | MINIMED 780G Device, Durable Pump | 2025 | |
| 2025-07-30 | Medtronic, Inc. | $148 | Food and Beverage | In-kind items and services | MINIMED 780G Device, Durable Pump | 2025 | |
| 2025-07-30 | Medtronic, Inc. | $120 | Travel and Lodging | In-kind items and services | MINIMED 780G Device, Durable Pump | 2025 | |
| 2025-07-30 | Medtronic, Inc. | $36 | Travel and Lodging | In-kind items and services | MINIMED 780G Device, Durable Pump | 2025 | |
| 2025-07-30 | Insulet Corporation | $18 | Food and Beverage | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2025 | |
| 2025-07-29 | Amgen Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-07-29 | Amgen Inc. | $367 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-07-29 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | SYNTHROID Drug, IMMUNOLOGY | 2025 | |
| 2025-07-29 | Amgen Inc. | $3 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-07-28 | Amgen Inc. | $1,485 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-07-28 | Novartis Pharmaceuticals Corporation | $17 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2025 | |
| 2025-07-28 | Novartis Pharmaceuticals Corporation | $0 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2025 | |
| 2025-07-24 | Amgen Inc. | $29 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-07-24 | Medtronic, Inc. | $14 | Travel and Lodging | In-kind items and services | MINIMED 780G Device, Durable Pump | 2025 | |
| 2025-07-23 | Ascendis Pharma Endocrinology Inc | $26 | Food and Beverage | In-kind items and services | Yorvipath Drug, Endocrinology | 2025 | |
| 2025-07-23 | Amgen Inc. | $6 | Food and Beverage | In-kind items and services | REPATHA Biological, Cardiovascular | 2025 | |
| 2025-07-22 | Amgen Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-07-22 | Amgen Inc. | $734 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-07-22 | Medtronic, Inc. | $22 | Food and Beverage | In-kind items and services | MINIMED 780G Device, Durable Pump | 2025 | |
| 2025-07-22 | Lilly USA, LLC | $15 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-07-18 | Amgen Inc. | $1,184 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-07-18 | Amgen Inc. | $140 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-07-17 | Amgen Inc. | $1,171 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-07-17 | Amgen Inc. | $134 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-07-16 | Dexcom, Inc. | $16 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-07-16 | Medtronic, Inc. | $8 | Food and Beverage | In-kind items and services | MINIMED 780G Device, Durable Pump | 2025 | |
| 2025-07-15 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | SYNTHROID Drug, IMMUNOLOGY | 2025 | |
| 2025-07-14 | Radius Health, Inc. | $21 | Food and Beverage | In-kind items and services | Tymlos Drug, Endocrinology | 2025 | |
| 2025-07-14 | Madrigal Pharmaceuticals | $18 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-07-11 | Dexcom, Inc. | $3 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-07-02 | Medtronic, Inc. | $39 | Food and Beverage | In-kind items and services | MINIMED 780G Device, Durable Pump | 2025 | |
| 2025-07-02 | Corcept Therapeutics | $17 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2025 | |
| 2025-07-01 | Amgen Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-07-01 | Amgen Inc. | $734 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-07-01 | Amgen Inc. | $65 | Travel and Lodging | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-07-01 | Amgen Inc. | $42 | Food and Beverage | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-07-01 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | SYNTHROID Drug, IMMUNOLOGY | 2025 | |
| 2025-06-30 | Xeris Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | GVOKE HYPOPEN Drug, Diabetes | 2025 | |
| 2025-06-27 | Amgen Inc. | $166 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-06-26 | Amgen Inc. | $117 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-06-24 | Medtronic, Inc. | $28 | Food and Beverage | In-kind items and services | MINIMED 780G Device, Durable Pump | 2025 | |
| 2025-06-24 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | SYNTHROID Drug, IMMUNOLOGY | 2025 | |
| 2025-06-24 | Medtronic, Inc. | $12 | Food and Beverage | In-kind items and services | MINIMED 780G Device, Durable Pump | 2025 | |
| 2025-06-23 | Lilly USA, LLC | $11 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-06-19 | Novo Nordisk Inc | $3,836 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-06-19 | Novo Nordisk Inc | $1,174 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-06-19 | Novo Nordisk Inc | $119 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-06-18 | Amgen Inc. | $15 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-06-17 | Madrigal Pharmaceuticals | $42 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-06-17 | Dexcom, Inc. | $18 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-06-16 | Radius Health, Inc. | $19 | Food and Beverage | In-kind items and services | Tymlos Drug, Endocrinology | 2025 | |
| 2025-06-13 | Abbott Laboratories | $16 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-06-10 | Novartis Pharmaceuticals Corporation | $18 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2025 | |
| 2025-06-10 | Novartis Pharmaceuticals Corporation | $0 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2025 | |
| 2025-06-09 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | SYNTHROID Drug, IMMUNOLOGY | 2025 | |
| 2025-06-06 | Amgen Inc. | $314 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-06-04 | Dexcom, Inc. | $14 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-05-22 | Novo Nordisk Inc | $4,766 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-22 | Novo Nordisk Inc | $964 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-22 | Novo Nordisk Inc | $38 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-22 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | SYNTHROID Drug, IMMUNOLOGY | 2025 | |
| 2025-05-22 | Novo Nordisk Inc | $19 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-05-20 | Amgen Inc. | $16 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-05-19 | Xeris Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | GVOKE HYPOPEN Drug, Diabetes | 2025 | |
| 2025-05-16 | Amgen Inc. | $314 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-05-15 | Amgen Inc. | $106 | Travel and Lodging | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-05-15 | Amgen Inc. | $50 | Travel and Lodging | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-05-15 | Amgen Inc. | $22 | Food and Beverage | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-05-14 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | SYNTHROID Drug, IMMUNOLOGY | 2025 | |
| 2025-05-14 | Novartis Pharmaceuticals Corporation | $17 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2025 | |
| 2025-05-14 | Dexcom, Inc. | $1 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-05-14 | Novartis Pharmaceuticals Corporation | $0 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2025 | |
| 2025-05-13 | Mannkind Corporation | $20 | Food and Beverage | In-kind items and services | AFREZZA Drug, DIABETES MEDICINE | 2025 | |
| 2025-05-08 | Amgen Inc. | $1,659 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-05-08 | Dexcom, Inc. | $14 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-05-07 | Tandem Diabetes Care, Inc. | $21 | Food and Beverage | In-kind items and services | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-05-07 | Dexcom, Inc. | $1 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-05-06 | Novo Nordisk Inc | $3,022 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-06 | Novo Nordisk Inc | $83 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-06 | Radius Health, Inc. | $16 | Food and Beverage | In-kind items and services | Tymlos Drug, Endocrinology | 2025 | |
| 2025-05-05 | Amgen Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-05-05 | Amgen Inc. | $734 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-05-02 | Amgen Inc. | $2,936 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-05-02 | Amgen Inc. | $1,835 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-05-02 | Amgen Inc. | $122 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-05-01 | Amgen Inc. | $101 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-04-30 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | SYNTHROID Drug, IMMUNOLOGY | 2025 | |
| 2025-04-30 | Verity Pharmaceuticals Inc. | $19 | Food and Beverage | Cash or cash equivalent | Tlando Drug, Testosterone Replacement Therapy (TRT) | 2025 | |
| 2025-04-28 | Amneal Pharmaceuticals LLC | $15 | Food and Beverage | In-kind items and services | UNITHROID Drug, ENDOCRINOLOGY | 2025 | |
| 2025-04-24 | Novo Nordisk Inc | $4,766 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-24 | Novo Nordisk Inc | $1,019 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-24 | Novo Nordisk Inc | $121 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-23 | Amgen Inc. | $13 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-04-22 | Insulet Corporation | $25 | Food and Beverage | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2025 | |
| 2025-04-18 | Amgen Inc. | $145 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-04-17 | Amgen Inc. | $547 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-04-17 | Amgen Inc. | $312 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-04-17 | Amgen Inc. | $124 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-04-16 | Dexcom, Inc. | $18 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-04-15 | Amgen Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-04-15 | Amgen Inc. | $414 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-04-15 | Amgen Inc. | $367 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-04-15 | Novartis Pharmaceuticals Corporation | $16 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2025 | |
| 2025-04-13 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-04-11 | Amgen Inc. | $1,116 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-04-10 | Amgen Inc. | $137 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-04-09 | Novo Nordisk Inc | $4,766 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-09 | Novo Nordisk Inc | $1,176 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-09 | Novo Nordisk Inc | $124 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-09 | Xeris Pharmaceuticals, Inc. | $24 | Food and Beverage | In-kind items and services | RECORLEV Drug, Adrenal steroidogenesis inhibitor | 2025 | |
| 2025-04-09 | Novo Nordisk Inc | $19 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-04-07 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | SYNTHROID Drug, IMMUNOLOGY | 2025 | |
| 2025-04-07 | Corcept Therapeutics | $22 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2025 | |
| 2025-04-03 | Novo Nordisk Inc | $4,766 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-03 | Novo Nordisk Inc | $1,425 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-03 | Novo Nordisk Inc | $121 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-02 | Amgen Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-04-02 | Amgen Inc. | $367 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-04-02 | Amgen Inc. | $105 | Travel and Lodging | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-04-01 | Radius Health, Inc. | $20 | Food and Beverage | In-kind items and services | Tymlos Drug, Endocrinology | 2025 | |
| 2025-03-31 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | SYNTHROID Drug, IMMUNOLOGY | 2025 | |
| 2025-03-31 | Amgen Inc. | $12 | Food and Beverage | In-kind items and services | REPATHA Biological, Cardiovascular | 2025 | |
| 2025-03-28 | Amgen Inc. | $546 | Travel and Lodging | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-03-27 | Amgen Inc. | $122 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-03-26 | Lilly USA, LLC | $19 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-03-25 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-03-25 | Lilly USA, LLC | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-03-24 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-03-24 | Amneal Pharmaceuticals LLC | $19 | Food and Beverage | In-kind items and services | UNITHROID Drug, ENDOCRINOLOGY | 2025 | |
| 2025-03-19 | Lilly USA, LLC | $1,122 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-03-19 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-03-19 | Lilly USA, LLC | $12 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-03-18 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | SYNTHROID Drug, IMMUNOLOGY | 2025 | |
| 2025-03-18 | Amgen Inc. | $11 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 |
The latest 200 records of 2,487.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2023-09-11 | Eli Lilly and Company | DISCOVERESEARCH INC | $1,061 | A PHASE 3 RANDOMIZED OPEN-LABEL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ONCE DAILY ORAL LY3502970 COMPARED WITH | 2023 |
| 2023-08-31 | Eli Lilly and Company | DISCOVERESEARCH INC | $265 | A STUDY OF ORFORGLIPRON (LY3502970) IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH DIET | 2023 |
| 2023-05-11 | ABBVIE INC. | DISCOVER RESEARCH INC | $2,000 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2023 |
| 2023-02-16 | ABBVIE INC. | DISCOVER RESEARCH INC | $93 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2023 |
| 2023-02-16 | ABBVIE INC. | DISCOVER RESEARCH INC | $93 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2023 |
| 2023-02-14 | ABBVIE INC. | DISCOVER RESEARCH INC | $192 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2023 |
| 2023-02-14 | ABBVIE INC. | DISCOVER RESEARCH INC | $192 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2023 |
| 2023-02-14 | ABBVIE INC. | DISCOVER RESEARCH INC | $64 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2023 |
| 2023-02-14 | ABBVIE INC. | DISCOVER RESEARCH INC | $192 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2023 |
| 2023-02-14 | ABBVIE INC. | DISCOVER RESEARCH INC | $128 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2023 |
| 2023-02-14 | ABBVIE INC. | DISCOVER RESEARCH INC | $64 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2023 |
| 2023-02-14 | ABBVIE INC. | DISCOVER RESEARCH INC | $64 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2023 |
| 2023-02-14 | ABBVIE INC. | DISCOVER RESEARCH INC | $64 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2023 |
| 2023-02-07 | ABBVIE INC. | DISCOVER RESEARCH INC | $187 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2023 |
| 2023-02-07 | ABBVIE INC. | DISCOVER RESEARCH INC | $187 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2023 |
| 2023-02-07 | ABBVIE INC. | DISCOVER RESEARCH INC | $281 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2023 |
| 2023-02-07 | ABBVIE INC. | DISCOVER RESEARCH INC | $187 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2023 |
| 2023-02-02 | ABBVIE INC. | DISCOVER RESEARCH INC | $3,400 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2023 |
| 2023-02-02 | ABBVIE INC. | DISCOVER RESEARCH INC | $1,000 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2023 |
| 2022-10-12 | ABBVIE INC. | DISCOVER RESEARCH INC | $242 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2022 |
| 2022-09-08 | ABBVIE INC. | DISCOVER RESEARCH INC | $1,210 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2022 |
| 2022-08-10 | ABBVIE INC. | DISCOVER RESEARCH INC | $6,186 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2022 |
| 2022-07-07 | ABBVIE INC. | DISCOVER RESEARCH INC | $242 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2022 |
| 2022-06-08 | ABBVIE INC. | DISCOVER RESEARCH INC | $825 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2022 |
| 2022-06-02 | ABBVIE INC. | DISCOVER RESEARCH INC | $400 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2022 |
| 2022-05-05 | ABBVIE INC. | DISCOVER RESEARCH INC | $2,117 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2022 |
| 2022-04-07 | ABBVIE INC. | DISCOVER RESEARCH INC | $1,462 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2022 |
| 2022-03-24 | ABBVIE INC. | DISCOVER RESEARCH INC | $10,200 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2022 |
| 2022-02-09 | ABBVIE INC. | DISCOVER RESEARCH INC | $1,000 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2022 |
| 2022-02-03 | ABBVIE INC. | DISCOVER RESEARCH INC | $791 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2022 |
| 2022-01-06 | ABBVIE INC. | DISCOVER RESEARCH INC | $1,373 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2022 |
| 2022-01-04 | ABBVIE INC. | DISCOVER RESEARCH INC | $150 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2022 |
| 2022-01-04 | ABBVIE INC. | DISCOVER RESEARCH INC | $192 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2022 |
| 2022-01-04 | ABBVIE INC. | DISCOVER RESEARCH INC | $150 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2022 |
| 2022-01-04 | ABBVIE INC. | DISCOVER RESEARCH INC | $192 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascula | 2022 |
| 2021-12-29 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $2,500 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-12-09 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $116 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-11-09 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $3,321 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-10-07 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $1,491 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-07-29 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $3,242 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-07-22 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $93 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-07-08 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $7,396 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-05-27 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $1,023 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-04-29 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $8,470 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-04-14 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $2,025 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-03-30 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $950 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-03-02 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $5,751 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-02-25 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $2,975 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-02-02 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $1,000 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-01-28 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $1,343 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-01-08 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $93 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-01-08 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $93 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-01-08 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $93 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-01-07 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $187 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-01-04 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $187 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-01-04 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $187 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-01-04 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $187 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2021-01-04 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $187 | Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (T | 2021 |
| 2020-12-30 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $93 | M16-100 | 2020 |
| 2020-12-30 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $93 | M16-100 | 2020 |
| 2020-12-16 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $614 | M16-100 | 2020 |
| 2020-11-25 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $1,656 | M16-100 | 2020 |
| 2020-10-16 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $10,177 | M16-100 | 2020 |
| 2020-10-16 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $731 | M16-100 | 2020 |
| 2020-09-17 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $963 | M16-100 | 2020 |
| 2020-08-17 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $37 | M16-100 | 2020 |
| 2020-07-15 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $549 | M16-100 | 2020 |
| 2020-07-10 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $163 | M16-100 | 2020 |
| 2020-06-15 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $484 | M16-100 | 2020 |
| 2020-04-20 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $2,933 | M16-100 | 2020 |
| 2020-04-17 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $64 | M16-100 | 2020 |
| 2020-04-17 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $64 | M16-100 | 2020 |
| 2020-04-17 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $64 | M16-100 | 2020 |
| 2020-04-17 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $64 | M16-100 | 2020 |
| 2020-04-17 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $64 | M16-100 | 2020 |
| 2020-04-17 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $1,000 | M16-100 | 2020 |
| 2020-03-19 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $1,013 | M16-100 | 2020 |
| 2020-01-21 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $484 | M16-100 | 2020 |
| 2019-12-11 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $1,429 | M16-100 | 2019 |
| 2019-10-15 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $2,607 | M16-100 | 2019 |
| 2019-09-13 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $889 | M16-100 | 2019 |
| 2019-08-19 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $1,039 | M16-100 | 2019 |
| 2019-07-15 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $3,828 | M16-100 | 2019 |
| 2019-06-20 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $5,420 | M16-100 | 2019 |
| 2019-05-28 | Novo Nordisk AS | DISCOVERESEARCH | $3,605 | NN1218-4113 | 2019 |
| 2019-05-28 | Novo Nordisk AS | DISCOVERESEARCH | $1,000 | NN1218-4113 | 2019 |
| 2019-05-28 | Novo Nordisk AS | DISCOVERESEARCH | $500 | NN1218-4113 | 2019 |
| 2019-05-28 | Novo Nordisk AS | DISCOVERESEARCH | $500 | NN1218-4113 | 2019 |
| 2019-05-16 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $6,024 | M16-100 | 2019 |
| 2019-05-13 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $1,300 | M16-100 | 2019 |
| 2019-04-16 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $18,795 | M16-100 | 2019 |
| 2019-03-29 | Novo Nordisk AS | DISCOVERESEARCH | $1,431 | NN1218-4113 | 2019 |
| 2019-03-22 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $11,824 | M16-100 | 2019 |
| 2019-01-22 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $8,425 | M16-100 | 2019 |
| 2019-01-22 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $1,000 | M16-100 | 2019 |
| 2019-01-08 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $7,500 | M16-100 | 2019 |
| 2019-01-08 | ABBVIE INC. | DISCOVERESEARCH BEAUMONT | $4,000 | M16-100 | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Beaumont, TX, county Jefferson County, TX, state Texas; placed by its city name.
| Measure | Place (city or town) Beaumont, TX | County Jefferson County, TX | State Texas |
|---|---|---|---|
| Population B01003 | 113,279 | 253,878 | 30,188,424 |
| Population, 2020 census P1 | 115,282 | 256,526 | 29,145,505 |
| Median age B01002 | 35.3 | 37.0 | 35.6 |
| Under 18 B01001 | 25.3% | 24.6% | 25.0% |
| 65 and over B01001 | 16.3% | 15.5% | 13.4% |
| Households B11001 | 45,001 | 94,807 | 10,992,816 |
| Foreign born B05002 | 11.0% | 12.1% | 17.6% |
| Median household income B19013 | $56,997 | $60,026 | $78,476 |
| Median family income B19113 | $71,096 | $75,099 | $94,599 |
| Per capita income B19301 | $32,642 | $32,101 | $40,752 |
| Poverty rate B17001 | 21.2% | 19.5% | 13.8% |
| Unemployment rate B23025 | 6.4% | 6.3% | 5.3% |
| Civilian labor force B23025 | 52,630 | 110,898 | 15,233,563 |
| Mean commute (minutes) B08013 | 20.3 | 21.2 | 26.7 |
| Bachelor's degree or higher B15003 | 24.9% | 19.7% | 33.8% |
| Housing units B25001 | 52,439 | 109,884 | 12,128,515 |
| Owner-occupied B25003 | 55.3% | 62.5% | 62.6% |
| Renters B25003 | 44.7% | 37.5% | 37.4% |
| Median home value B25077 | $166,400 | $169,500 | $283,800 |
| Median gross rent B25064 | $1,121 | $1,117 | $1,403 |
| White, not Hispanic B03002 | 26.3% | 36.3% | 39.1% |
| Black B03002 | 45.2% | 32.7% | 11.9% |
| Hispanic or Latino B03002 | 20.8% | 24.1% | 39.7% |
| Asian B03002 | 3.8% | 3.8% | 5.5% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Beaumont, TX.
Comments